Jordi Ochando
Overview
Explore the profile of Jordi Ochando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
4322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LILRB3 genetic variation is associated with kidney transplant failure in African American recipients
Sun Z, Yi Z, Wei C, Wang W, Ren T, Cravedi P, et al.
Nat Med
. 2025 Mar;
PMID: 40065170
African American (AA) kidney transplant recipients exhibit a higher rate of graft loss compared with other racial and ethnic populations, highlighting the need to identify causative factors. Here, in the...
2.
Presa J, Arranz-Herrero J, Alvarez-Losa L, Rius-Rocabert S, Pozuelo M, Lalueza A, et al.
Eur Respir Rev
. 2025 Jan;
34(175).
PMID: 39778922
Background: The morbidity and mortality associated with influenza viruses are a significant public health challenge. Annual vaccination against circulating influenza strains reduces hospitalisations and increases survival rates but requires a...
3.
4.
Jacobs M, Maas R, Jonkman I, Negishi Y, Tielemans Zamora W, Yanginlar C, et al.
Cell Rep
. 2024 Aug;
43(9):114664.
PMID: 39178113
Trained immunity is characterized by histone modifications and metabolic changes in innate immune cells following exposure to inflammatory signals, leading to heightened responsiveness to secondary stimuli. Although our understanding of...
5.
Jonkman I, Jacobs M, Negishi Y, Yanginlar C, Martens J, Baltissen M, et al.
Am J Transplant
. 2024 Aug;
24(11):2022-2033.
PMID: 39147201
The innate immune system plays an essential role in regulating the immune responses to kidney transplantation, but the mechanisms through which innate immune cells influence long-term graft survival are unclear....
6.
Themistocleous S, Argyropoulos C, Vogazianos P, Shiamakkides G, Noula E, Nearchou A, et al.
JMIR Public Health Surveill
. 2024 Apr;
10():e47241.
PMID: 38573762
Background: The VACCELERATE Pan-European Scientific network aims to strengthen the foundation of vaccine trial research across Europe by following the principles of equity, inclusion, and diversity. The VACCELERATE Volunteer Registry...
7.
Poulimeneas D, Koniordou M, Kousi D, Merakou C, Kopsidas I, Tsopela G, et al.
Vaccines (Basel)
. 2023 Dec;
11(12).
PMID: 38140188
Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE...
8.
Salmanton-Garcia J, Wipfler P, Valle-Simon P, Merakou C, Kopsidas I, Bethe U, et al.
Vaccine
. 2023 May;
41(26):3915-3922.
PMID: 37210309
Background: The inconsistent European vaccine trial landscape rendered the continent of limited interest for vaccine developers. The VACCELERATE consortium created a network of capable clinical trial sites throughout Europe. VACCELERATE...
9.
Gonzalez-Perez M, Baranda J, Berges-Buxeda M, Conde P, Perez-Olmeda M, Lozano-Ojalvo D, et al.
Pharmaceuticals (Basel)
. 2023 Apr;
16(4).
PMID: 37111331
Continuous evaluation of the coronavirus disease 2019 (COVID-19) vaccine effectiveness in hemodialysis (HD) patients is critical in this immunocompromised patient group with higher mortality rates due to severe acute respiratory...
10.
Arranz-Herrero J, Presa J, Rius-Rocabert S, Utrero-Rico A, Arranz-Arija J, Lalueza A, et al.
Int J Infect Dis
. 2023 Apr;
131:173-179.
PMID: 37030656
Background: The clinical burden of influenza is increasing worldwide. Aging, immunosuppression, and underlying respiratory illness are determinants of poor clinical outcomes, including greater mortality. Bacterial infections seem to be the...